Prevalence, characteristics and prognostic significance of anemia in daily practice

QJM: An International Journal of Medicine

Volumn 105, Issue 4, 2012, Pages 345-354

  Terrier, B ^a   Resche Rigon, M ^b   Andres, E ^c   Bonnet, F ^d   Hachulla, E ^e   Marie, I ^f   Rosenthal, E ^g   Cacoub, P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f ROUEN UNIVERSITY HOSPITAL   (France)

^g UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; C REACTIVE PROTEIN; CORTICOSTEROID; CREATININE; CYANOCOBALAMIN; ERYTHROPOIETIN; FIBRINOGEN; FOLIC ACID; HEMOGLOBIN; IRON;

ADULT; AGE; AGED; ANEMIA; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; FRANCE; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; IRON DEFICIENCY; KIDNEY FAILURE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SURVIVAL TIME; VITAMIN DEFICIENCY;

EID: 84859088351     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcr230     Document Type: Article

References (27)

1. Lipschitz D. Medical and functional consequences of anemia in the elderly. J Am Geriatr Soc 2003; 51:S10-3.
2. Robinson BM, Joffe MM, Berns JS, Pisoni RL, Port FK, Feldman HI. Anemia and mortality in hemodialysis patients: accounting for morbidity and treatment variables updated over time. Kidney Int 2005; 68:2323-30.
3. Weiner DE, Tighiouart H, Vlagopoulos PT, Griffith JL, Salem DN, Levey AS, et al. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol 2005; 16:1803-10.
4. Izaks GJ, Westendorp RG, Knook DL. The definition of anemia in older persons. JAMA 1999; 281:1714-7.
5. Chaves PH, Xue QL, Guralnik JM, Ferrucci L, Volpato S, Fried LP. What constitutes normal hemoglobin concentration in community-dwelling disabled older women? J Am Geriatr Soc 2004; 52:1811-6.
6. Thomas DR. Anemia and quality of life: unrecognized and undertreated. J Gerontol A Biol Sci Med Sci 2004; 59:238-41.
7. Penninx BW, Pahor M, Cesari M, Corsi AM, Woodman RC, Bandinelli S, et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc 2004; 52:719-24.
8. Foley RN, Parfrey PS. Anemia in predialysis chronic renal failure: What are we treating? J Am Soc Nephrol 1998; 9:S82-4.
9. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the american heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 2003; 108:2154-69.
10. McClellan W, Aronoff SL, Bolton WK, Hood S, Lorber DL, Tang LK, et al. The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin 2004; 20:1501-10.
11. Tang YD, Katz SD. Anemia in chronic heart failure: Prevalence, etiology, clinical correlates, and treatment options. Circulation 2006; 113:2454-61.
12. Bokemeyer C, Oechsle K, Hartmann JT. Anaemia in cancer patients: pathophysiology, incidence and treatment. Eur J Clin Invest 2005; 35(Suppl. 3):26-31.
13. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the united states: evidence for a high rate of unexplained anemia. Blood 2004; 104:2263-8.
14. Ania BJ, Suman VJ, Fairbanks VF, Rademacher DM, Melton LJ 3rd. Incidence of anemia in older people: an epidemiologic study in a well defined population. J Am Geriatr Soc 1997; 45:825-31.
15. Churchill DN, Blake PG, Jindal KK, Toffelmire EB, Goldstein MB. Clinical practice guidelines for initiation of dialysis. Canadian society of nephrology. J Am Soc Nephrol 1999; 10(Suppl. 13):S289-91.
16. O'Meara E, de Denus S. Management of anemia and iron deficiency in heart failure. Curr Treat Options Cardiovasc Med 2010; 12:532-48.
17. van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 1999; 18:681-94.
18. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011; 30:377-99.
19. Hosmer DW, Hosmer T, Le Cessie S, Lemeshow S. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med 1997; 16:965-80.
20. Ngo K, Kotecha D, Walters JA, Manzano L, Palazzuoli A, van Veldhuisen DJ, et al. Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients. Cochrane Database Syst Rev 2010; CD007613.
21. Parfrey PS. Critical appraisal of randomized controlled trials of anemia correction in patients with renal failure. Curr Opin Nephrol Hypertens 2011; 20:177-81.
22. Molnar MZ, Mucsi I, Macdougall IC, Marsh JE, Yaqoob M, Main J, et al. Prevalence and management of anaemia in renal transplant recipients: Data from ten european centres. Nephron Clin Pract 2011; 117:c127-34.
23. Beyer I, Compte N, Busuioc A, Cappelle S, Lanoy C, Cytryn E. Anemia and transfusions in geriatric patients: A time for evaluation. Hematology 2010; 15:116-21.
24. Vanasse GJ, Berliner N. Anemia in elderly patients: an emerging problem for the 21st century. Hematology Am Soc Hematol Educ Program 2010; 2010:271-5.
25. Drueke TB, Locatelli F, Clyne N, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355:2071-84.
26. Clement FM, Klarenbach S, Tonelli M, Johnson JA, Manns BJ. The impact of selecting a high hemoglobin target level on health-related quality of life for patients with chronic kidney disease: a systematic review and meta-analysis. Arch Intern Med 2009; 169:1104-12.
27. Pirker R. Erythropoiesis-stimulating agents in patients with cancer: update on safety issues. Expert Opin Drug Saf 2009; 8:515-22.